SINOVAC BIOTECH LTD's ticker is SVA and the CUSIP is P8696W104. A total of 32 filers reported holding SINOVAC BIOTECH LTD in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $2,136,000 | -60.0% | 271,072 | -64.3% | 0.10% | -64.7% |
| Q3 2017 | $5,342,000 | +180.0% | 758,859 | +168.5% | 0.28% | +167.0% |
| Q2 2017 | $1,908,000 | +188.7% | 282,611 | +144.8% | 0.11% | +241.9% |
| Q1 2017 | $661,000 | +352.7% | 115,446 | +366.7% | 0.03% | +416.7% |
| Q4 2016 | $146,000 | -57.2% | 24,739 | -57.2% | 0.01% | -40.0% |
| Q3 2016 | $341,000 | -0.6% | 57,800 | 0.0% | 0.01% | 0.0% |
| Q2 2016 | $343,000 | – | 57,800 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 2,718,735 | $340,500,000 | 6.32% |
| Vivo Capital, LLC | 5,900,000 | $38,173,000 | 4.21% |
| Neumann Advisory Hong Kong Ltd | 315,586 | $2,042 | 0.72% |
| Yorktown Management & Research Co Inc | 74,893 | $485,000 | 0.63% |
| Skandinaviska Enskilda Banken AB (publ) | 40,000 | $259,000 | 0.00% |
| Renaissance Technologies | 2,375,841 | $1,537,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 1,687 | $11,000 | 0.00% |
| NORTHERN TRUST CORP | 13,787 | $55,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 412 | $27,000 | 0.00% |